For more information, visit: https://labs.dgsom.ucla.edu/deng/pages/our_team Mario C. Deng, MD, Professor of Medicine, Advanced Heart Failure/Mechanical Support/Heart Transplant, David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center. Dr. Deng is the co-inventor of the first diagnostic leukocyte gene expression profiling biomarker test in transplantation medicine, AllomapTM, that gained FDA clearance and international guideline acceptance to rule-out heart transplant rejection without invasive endomyocardial biopsies. Dr. Deng maintains a core position at the intersection between clinical cardiology and bench-to-bedside translational research. Dr. Deng is now focusing on developing a genomic blood test to better predict outcomes in patients with various forms of heart failure (MyLeukoMAPTM). Linking systems biology back into the clinical framework of a humanistically sound high–tech modern medicine encounter is reflected in Dr. Deng’s most recent research collaboration with Prof. Federica Raia (UCLA DGSOM and GSEIS) in the “Relational Medicine” project and “The Science in the Making” project. Galyna Bondar, PhD has over 30 years of biological research experience. She started her career as a lecturer and scientist at Dnepropetrovsk National University, Ukraine, where she earned her PhD in biology in 2002. Throughout her career, she gained extensive experience with analytical techniques in biochemistry and cellular and molecular biology.

What Men Google at 2 am
216 views

Men's Health Beyond the Bedroom
189 views

Aging is a Privilege: A New Perspective on Geriatric Care
296 views

The Evolution of Aortic Surgery | UCLA Health Aortic Care
101 views

Repairing Ascending Aortic Aneurysms | UCLA Health Aortic Care
168 views

Reducing the Risks of Aortic Aneurysm Surgery | UCLA Health Aortic Care
111 views